WB, IP, IF-IC
H M R Mk
Endogenous
75
Rabbit IgG
#Q9H4L4
26168
Product Information
Product Usage Information
| Application | Dilution |
|---|---|
| Western Blotting | 1:1000 |
| Immunoprecipitation | 1:100 |
| Immunofluorescence (Immunocytochemistry) | 1:400 |
Storage
Specificity / Sensitivity
Species Reactivity:
Human, Mouse, Rat, Monkey
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Phe48 of human SENP3 protein.
Background
SENP3 is a member of the SENP (sentrin/SUMO-specific protease) family. The SUMO protease localizes to the nucleolus and catalyzes the release of SUMO2 and SUMO3 monomers from sumoylated substrates (1,2). SENP3 has been reported responsible for the removal of SUMO2/3 from many important target proteins, and regulates their function and stability. Desumoylation of MEF2D (removal of SUMO2/3) leads to an increase of MEF2D transcriptional activation (3). SENP3 enhances the binding of HIF-1α to p300 by deconjugation of SUMO2/3 from p300, leading to the upregulation of HIF-1α transcriptional activity and angiogenesis (4). SENP3 localizes to nucleolus through its binding to the nucleolar protein nucleophosmin (NPM1) (5), and its deconjugation activity towards NPM1 is required for rRNA processing during ribosomal biogenesis (6). Under mild oxidative stress, SENP3 colocalizes with PML, and desumoylates and inhibits the function of PML to promote cell proliferation (7). SENP3 levels are tightly controlled in cells; NPM1, Arf, CHIP, and HSP90 have been shown to regulate the stability of SENP3, either by direct or indirect interaction (8,9).
- Nishida, T. et al. (2000) Eur J Biochem 267, 6423-7.
- Gong, L. and Yeh, E.T. (2006) J Biol Chem 281, 15869-77.
- Grégoire, S. and Yang, X.J. (2005) Mol Cell Biol 25, 2273-87.
- Huang, C. et al. (2009) EMBO J 28, 2748-62.
- Yun, C. et al. (2008) J Cell Biol 183, 589-95.
- Haindl, M. et al. (2008) EMBO Rep 9, 273-9.
- Han, Y. et al. (2010) J Biol Chem 285, 12906-15.
- Kuo, M.L. et al. (2008) Cell Cycle 7, 3378-87.
- Yan, S. et al. (2010) EMBO J, Epub ahead of print.
Species Reactivity
Species reactivity is determined by testing in at least one approved application (e.g., western blot).
Western Blot Buffer
IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v BSA, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.
Applications Key
WB: Western Blotting IP: Immunoprecipitation IF-IC: Immunofluorescence (Immunocytochemistry)
Cross-Reactivity Key
H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected
Trademarks and Patents
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.